Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 25 Jan 2006 |
| Novozymes, group financial statement for 2005 | 24 Jan 2006 |
| Novozymes, share buy-back programme completed (section 28) | 20 Dec 2005 |
| Novozymes, Trading by insiders in Novozymes A/S B shares - statement no. 27, 2005 | 10 Nov 2005 |
| Novozymes, Group financial statement for the first nine months of 2005 | 27 Oct 2005 |